T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Trading Down 4.5 %

NASDAQ:TTOO opened at $0.21 on Wednesday. T2 Biosystems has a 52-week low of $0.21 and a 52-week high of $6.95. The business’s fifty day moving average is $0.39 and its 200 day moving average is $1.83.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.